ISCP 2025 – 30 Congreso Científico Anual de la Sociedad Internacional de Farmacoterapia Cardiovascular

Jueves, 25 de septiembre de 2025 // 08:30 h. – 17:15 h. 

Palacio de Exposiciones y Congresos ‘Ciudad de Oviedo’

09:30 h. - 10:45 h. Taller clínico de electrocardiografía 
Dr. Julio Casares. Cardiología. 
08:30 - 09:15 h. Oral communications
Moderator: Camila Gallino
09:15 - 09:30 h. Opening Ceremony
Pablo Avanzas (Spain)
Jesús María de la Hera (Spain)
Session 1: Diabetes Mellitus in 2025
Moderators: Elias Delgado (Spain) and Augusto Gallino (Swiss)
09:30 - 09:45 h. Is there a role for metformin?
Heinz Drexel (Austria)
09:45 - 10:00 h. iSGLT2 and GLP1 agonists for everyone?
Krzysztof Filipiak (Poland)
10:00 - 10:15 h. Glucose sensors and insulin pumps
Elias Delgado (Spain)
10:15 - 10:30 h. Debate
10:30 - 11:00 h. Coffee Break
11:00 - 11:30 h. KeyNote Lecture: “Prof Henry H. Neufeld”
Moderators: Jesús María de la Hera (Spain) and Pablo Avanzas (Spain)
Lecturer: Juan Tamargo (Spain)
Session 2: Secondary prevention - Focus on lipid-lowering therapy
Joint session with Primastcar
Moderators: M. A. Álvarez Cabo (Spain) and Antoni Martínez-Rubio (Spain)
11:30 - 11:45 h. The new kids on the block: IPE, bempedoic acid
Sergio Hevia (Spain)
11:45 - 12:00 h. When statins are not enough…. Non-Oral pharmacological alternatives
Juán Rondán (Spain)
12:00 - 12:15 h. Familial Hypercholesterolemia, new opportunities for difficult patients
Rodrigo Alonso (Chile)
12:15 - 12:30 h. Lipid-lowering targets and therapy in patients with DM
Alberto Lorenzatti (Argentina)
12:30 - 12:45 h. Quality in secondary prevention: A national Survey
Jessica Ares (Spain)
12:45 - 13:00 h. Primastcar positioning in lipid-lowering therapy
Julio Casares (Spain)
13:00 - 13:15 h. Debate
13:15 - 13:45 h. Workshop: playing with drug interactions
Moderators: Ana Lozano (Spain) and Craig Beavers (United States)
Lecturer: TBD
13:45 - 14:30 h. Lunch
Session 3: Specific peculiarities of heart failure in…
Moderators: Beatriz Díaz Molina (Spain) and Felipe Martínez (Argentina)
14:30 - 14:45 h. Diabetic population: When to use NT proBNP?
TBD
14:45 - 15:00 h. Preserved ejection fraction
Gheorghe-Andrei Dan (Romania)
15:00 - 15:15 h. Cardiac amyloidosis: Should I prescribe neurohormonal blockade?
Koji Hasegawa (Japan)
15:15 - 15:30 h. Debate
Session 4: When medical treatment is not enough…
Moderators: Pablo Avanzas (Spain) and Jack Tan (Singapore)
15:30 - 15:45 h. Edge to edge therapies: who and when?
Isaac Pascual (Spain)
15:45 - 16:00 h. TAVR: who and when?
Raquel del Valle (Spain)
16:00 - 16:15 h. Resynchronization: who and when?
Fabian Fastenrath
16:15 - 16:30 h. Current and future stents: who and when?
Jesús María de la Torre (Spain)
16:30 - 16:45 h. Debate
16:45 - 17:15 h. End of day

Viernes, 26 de septiembre de 2025 // 08:30 h. – 17:15 h. 

Session 6: Newer perspective in the management of hypertension. Joint session with EAPE
Moderators: Dennis Cokkinos (Greece) and Thomas Kahan (Sweden)
09:00 - 09:15 h. All diseases are a vicious cycle to be interrupted
Dennis Cokkinos (Greece)
09:15 - 09:30 h. Decisions about antihypertensive treatment should focus on reducing CV risk
José María Fernández (Spain)
09:30 - 09:45 h. Recommended drug strategies for antihypertensive therapy and for cardiovascular risk reduction
Celso Amodeo (Brazil)
09:45 - 10:00 h. Emerging antihypertensive medications
Giuseppe Mancia (Italy)
10:00 - 10:15 h. Combating hypertension-related arrhythmias
Gheorghe-Andrei Dan (Romania)
10:30 - 10:30 h. Debate
10:30 - 11:00 h. Keynote lecture: Wine consumption and Mediterranean diet. The key for longevity in Spain?
Moderators: Pablo Avanzas (Spain) and Antonio Fernández (Spain)
Lecturer: Miguel Ángel Martínez (Spain)
11:00 - 11:30 h. Coffee Break
Session 7: Obesity. Joint session with Sociedad Española de Cardiología
Moderators: Luis Rodríguez Padial (Spain) and Juan Carlos Kaski (UK)
11:30 - 11:45 h. The role of diet. How to implement a specific plan of healthy weight reduction
Ceferino Martínez (Spain)
11:45 - 12:00 h. Obesity: Is there a role for the cardiologist?
Luis Rodríguez Padial (Spain)
12:00 - 12:15 h. GLP1 agonists and more, when? how? Efficacy and safety
Antoni Martínez-Rubio (Spain)
12:15 - 12:30 h. Debate
Session 8: Cardio oncology
Moderators: Rebeca Lorca (Spain) and Juan Carlos Kaski (UK)
12:30 - 12:45 h. Is it possible to prevent heart failure due to cancer therapy?
Rebeca Lorca (Spain)
12:45 - 13:00 h. Cancer therapy and accelerated atherosclerosis: is there a link?
Alina Scridon (Romania)
13:00 - 13:15 h. Hypertension due to cancer therapy: how should we manage?
Álvaro González Franco (Spain)
13:15 - 13:30 h. Debate
13:30 - 14:15 h. Lunch
Session 9: Cardiomyopathies: New pharmacological therapies
Moderator: Alina Scridon
14:15 - 14:30 h. Advances in hypertrophic cardiomyopathy therapy
14:30 - 14:45 h. Advances in microcirculation therapy
Juan Carlos Kaski (UK)

Coste de inscripción:
Socios/FEA: 360€
Residentes: 300€
ISCP Full Members: 180€

Solicitados Créditos de Formación / Imprescindible inscripción previa

Organizan: 

Avalan: